RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
DiaSorin SpA Stock

DiaSorin SpA Employees 2024

DiaSorin SpA Employees

1,939

Ticker

DIA.MI

ISIN

IT0003492391

WKN

A0MTB2

In 2024, DiaSorin SpA employed 1,939 people, a 0% change from the 1,939 number of employees in the previous year.

DiaSorin SpA Aktienanalyse

What does DiaSorin SpA do?

DiaSorin SpA is an Italian medical technology company that specializes in the development and production of diagnostic solutions for serious diseases. The company was founded in 1968 in Saluggia, a small town in the Piedmont region of northern Italy. Since then, DiaSorin has experienced impressive growth and now operates worldwide. DiaSorin is a major player in the in-vitro diagnostics (IVD) market and offers a wide range of solutions for clinical laboratories and medical professionals. The company's business model is based on the development of innovative test systems that enable fast, reliable, and accurate diagnosis of diseases. The company's goal is to provide improved access to diagnostic opportunities for patients worldwide and support the entire medical practice. In its early days, DiaSorin mainly focused on the development and production of enzyme immunoassays (EIAs) and other immunochemical tests. However, over the years, the company has evolved and introduced a variety of product lines, including molecular diagnostic tests, automated immunoassay systems and instruments, and clinical laboratory software. Today, DiaSorin has four main business areas: Immunoassays, Molecular Biology, Automation, and Diagnosis Information Management. The Immunoassays business area, also known as diaMune, offers a wide range of immunoassay solutions based on various technologies, including chemiluminescence, ELISA, fluorescence, and multiplexing. The Molecular Biology business area, also known as DiaMolecular, develops and produces a broad spectrum of molecular diagnostic solutions, including tests for infectious diseases, oncological diseases, and genetic disorders. DiaMolecular's products provide fast, efficient, and highly accurate diagnosis of serious diseases, enabling early treatment and therapy. The third major business area, DiaSorin's automation solutions, offers instruments and automated testing systems that optimize laboratory processes, improve efficiency, and speed up test execution. These solutions not only increase the accuracy and reliability of diagnostic tests but also help reduce costs and workload in medical laboratories. Finally, DiaSorin's Diagnosis Information Management business area offers a variety of software solutions that assist medical professionals in managing and interpreting diagnostic data. These solutions enable faster and more accurate diagnosis and can also contribute to improving patient care and optimizing laboratory processes. DiaSorin is led by a strong and experienced management team committed to driving the company's growth through continuous innovation and expansion into new markets. With branches and subsidiaries around the world, DiaSorin is a key player in the global medical technology industry. Overall, DiaSorin is an innovative and forward-thinking company that continuously develops its technologies and solutions to improve the quality of life for millions of people worldwide. DiaSorin SpA ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Employees Details

Examining DiaSorin SpA's Employee Base

DiaSorin SpA's employees are a pivotal aspect of its operations, driving innovation, productivity, and growth. The size and composition of the workforce offer insights into the company's scale, diversity, and investment in human capital. Analyzing employee trends and data is essential for understanding DiaSorin SpA's operational capacity and future potential.

Year-to-Year Comparison

Assessing DiaSorin SpA's employee numbers year-over-year helps in identifying growth patterns, expansions, or contractions. An increasing employee count can indicate scaling operations and investment in talent, while a decrease may signal efficiency improvements, automation, or business challenges.

Impact on Investments

DiaSorin SpA's employee data impacts investment decisions by shedding light on the company’s operational efficiency, innovation capability, and sustainability. Investors assess workforce data to gauge the firm's potential to execute strategies, innovate, and adapt to market changes effectively.

Interpreting Employee Trends

Fluctuations in DiaSorin SpA’s employee numbers indicate changes in business strategy, operational demands, and market dynamics. Investors and analysts scrutinize these trends to evaluate the company’s strategic positioning, adaptability, and potential for sustainable growth.

Frequently Asked Questions about DiaSorin SpA stock

How many employees does DiaSorin SpA have this year?

DiaSorin SpA has 1,939 undefined employees this year.

How many employees did DiaSorin SpA have compared to the previous year?

Compared to the previous year, DiaSorin SpA had 0% more employees.

What impact did the number of employees have on the company DiaSorin SpA?

The number of employees has a direct impact on the efficiency and productivity of DiaSorin SpA. A higher number of employees can indicate that the company is growing and has more resources to achieve its goals, while a lower number of employees may suggest that the company is saving costs or facing difficulties in recruiting new employees.

What impact did the number of employees have on investors of DiaSorin SpA?

The number of employees can also have an impact on investors of DiaSorin SpA, as it can be an indicator of the company's growth and financial health. A higher number of employees can promise investors, while a lower number of employees may raise concerns.

How does an increase in equity capital of DiaSorin SpA affect the company?

An increase in equity of DiaSorin SpA can improve the financial strength of the company and increase its ability to make future investments and fulfill obligations.

How does a reduction in DiaSorin SpA's equity affect the company?

A reduction in equity of DiaSorin SpA can impair its financial stability and decrease its ability to fulfill future investments and obligations.

What are some factors that influence the equity of DiaSorin SpA?

Some factors that can influence the equity of DiaSorin SpA include, among others, revenue development, profit and loss statement, dividend payments, and investments.

Why is the equity of DiaSorin SpA so important for investors?

The equity of DiaSorin SpA is important for investors as it is an indicator of the company's financial stability and provides investors with information on the amount of financial backing the company has in terms of obligations and future investments.

How does the number of employees at DiaSorin SpA influence the company?

The number of employees at DiaSorin SpA can directly impact the growth and performance of the company. A higher number of employees can lead to increased capacity and productivity, while a lower number of employees may result in reduced efficiency and limitations.

How has the number of employees at DiaSorin SpA evolved in recent years?

In recent years, the number of employees at DiaSorin SpA has changed by 0.

How many employees does DiaSorin SpA currently have?

DiaSorin SpA currently has 1,939 undefined employees.

Why is the number of employees important for investors of DiaSorin SpA?

The number of employees is important for investors of DiaSorin SpA as it is an indicator of the growth potential and performance of the company. It also provides information on how the company is able to manage and recruit its workforce.

What strategic measures can DiaSorin SpA take to change the number of employees?

To change the number of employees, DiaSorin SpA can take various measures such as adjusting compensation packages, improving working conditions, conducting recruitment campaigns, and promoting a positive corporate culture. It is important for the company to conduct a thorough assessment of its situation to determine the best strategic actions to change its number of employees.

How much dividend does DiaSorin SpA pay?

Over the past 12 months, DiaSorin SpA paid a dividend of 1.1 EUR . This corresponds to a dividend yield of about 1.04 %. For the coming 12 months, DiaSorin SpA is expected to pay a dividend of 1.24 EUR.

What is the dividend yield of DiaSorin SpA?

The current dividend yield of DiaSorin SpA is 1.04 %.

When does DiaSorin SpA pay dividends?

DiaSorin SpA pays a quarterly dividend. This is distributed in the months of June, June, June, June.

How secure is the dividend of DiaSorin SpA?

DiaSorin SpA paid dividends every year for the past 0 years.

What is the dividend of DiaSorin SpA?

For the upcoming 12 months, dividends amounting to 1.24 EUR are expected. This corresponds to a dividend yield of 1.17 %.

In which sector is DiaSorin SpA located?

DiaSorin SpA is assigned to the 'Health' sector.

Wann musste ich die Aktien von DiaSorin SpA kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of DiaSorin SpA from 5/22/2024 amounting to 1.15 EUR, you needed to have the stock in your portfolio before the ex-date on 5/20/2024.

When did DiaSorin SpA pay the last dividend?

The last dividend was paid out on 5/22/2024.

What was the dividend of DiaSorin SpA in the year 2023?

In the year 2023, DiaSorin SpA distributed 1.05 EUR as dividends.

In which currency does DiaSorin SpA pay out the dividend?

The dividends of DiaSorin SpA are distributed in EUR.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von DiaSorin SpA

Our stock analysis for DiaSorin SpA Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of DiaSorin SpA Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.